Hepatitis C OnlineLogo
Section Navigation
Common TitlePOLARIS-2
Official Title Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials
Phase Phase III
ClinicalTrials.gov NCT02607800
Treatments
Sofosbuvir-Velpatasvir

Sofosbuvir-Velpatasvir

Tradename:EpclusaOther Names:SOF-VELClass:FDA-Approved
,
Sofosbuvir-Velpatasvir-Voxilaprevir

Sofosbuvir-Velpatasvir-Voxilaprevir

Tradename:VoseviOther Names:SOF-VEL-VOXClass:FDA-Approved
Funding
IndustryGilead Sciences
Open Slide Deck

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.